Chemistry - A European Journal
10.1002/chem.201804094
COMMUNICATION
Berthold Schenkel, and Dr. Gerhard Penn were most helpful.
TDS was an undergraduate researcher and UROP scholar. Dr.
Mycah Uehling and Dr. Nicholas White (MIT) provided helpful
feedback during the manuscript preparation.
[11] (a) Iwasaki, T.; Horikawa, H.; Matsumoto, K.; Miyoshi, M. J.
Org. Chem. 1977, 42, 2419. (b) Iwasaki, T.; Horikawa, H.;
Matsumoto, K.; Miyoshi, M. J. Bull. Chem. Soc. Jpn. 1977, 52,
8
26.
12] For single report involving Pd-catalyzed arylalkoxylation of
dha with ArN BF to generate products resembling IX, see: de
Azambuja, F.; Correia, C. R. D. Tet. Lett. 2011, 52, 42.
13] Chernyak, N.; Buchwald, S. L. J. Am. Chem. Soc. 2012, 134,
2466.
14] Hofling, S. B.; Hultsch, C.; Wester, H.-J.; Heinrich, M. R.
[
Keywords: captodative • dehydroalanine • aryldiazonium salts •
arylhydroxylation • UAAs • redox catalysis • continuous flow
2
4
[
1
[
•
UAAs
Tetrahedron 2008, 64, 11846.
[
1] For a latest review on the presence of dehydroalanine in
[15] For radical-based polymerization of dehydralanine, see: (a)
Tezuka, Y.; Tanaka, H. J. Appl. Polym. Sci. 2013, 127, 34. (b)
Mathias, L. J.; Hermes, R. E. Macromolecules 1988, 21, 11.
[16] To review diazonium safety guidelines developed at Merck,
see: Bassan, E.; Ruck, R. T.; Dienemann, E.; Emerson, K. M.;
Humphrey, G. R.; Raheem, I. T.; Tschaen, D. M.; Vickery, T. P.;
Wood, H. B.; Yasuda, N. Org. Process Res. Dev. 2013, 17, 1611
and ref. 1 therein.
naturally occurring peptides, see: Siodlak, D. Amino Acids 2015,
7, 1.
2] (a) Dehydroalanine readily undergoes nucleophilic additions,
4
[
see: Naidu, B. N.; Sorenson, M. E.; Connolly, T. P.; Ueda, Y. J.
Org. Chem. 2003, 68, 10098. (b) For an example of conjugate
addition based chemoselective ligation with dha residues, see:
Zhu, Y.; van der Donk, W. A. Org. Lett. 2001, 3, 1189. (c) For an
example involving dha-based diubiquitin activity probes, see:
Haj-Yahya, N.; Hemantha, H. P.; Meledin, R.; Bondalapati, S.;
Seenaiah, M.; Brik, A. Org. Lett. 2014, 16, 540.
[17] See supporting information for details.
[18] The side-product could not be identified through 1H/ C
NMR and GC-based analysis of the reaction mixture. Our
attempts for its isolation or crystallization also failed.
[ 19 ] (a) For a review on the aryl radical generation from
aryldiazoniums, see: Galli, C. Chem. Rev. 1988, 88, 765. (b) For
ferrocene-promoted radical formation, see: Galli, C. J. Chem.
Soc., Perkin Trans. 2 1981, 1459.
13
[
3] For a detailed review on lantibiotics, see: Bierbaum, G.; Sahl,
H.-G. Curr. Pharm. Biotechnol. 2009, 10, 2.
4] For a representative protocol involving Heck arylation with
dha followed by the enantioselective hydrogenation to access
UAA, see: Cann, R. O.; Chen, C.-P. H.; Gao, Q.; Hanson, R.
[
L.; Hsieh, D.; Li, J.; Lin, D.; Parsons, R. L.; Pendri, Y.; Nielsen, R. [20] Viehe, H. G.; Janousek, Z.; Merenyi, R. Acc. Chem. Res.
B.; Nugent, W. A.; Parker, W. L.; Quinlan, S.; Reising, N. P.;
1985, 18, 148.
Remy, B.; Sausker, J.; Wang, X. Org. Process Res. Dev. 2012,
[21] Hollister, K. A.; Conner, E. S.; Spell, M. L.; Deveaux, K.;
Maneval, L.; Beal, M. W.; Ragains, J. R. Angew. Chem. Int. Ed.
2015, 54, 7837.
16, 1953.
[
5] UAAs are used in peptide-based drugs: (a) Stevenazzi, A.;
Marchini, M.; Sandrone, G.; Vergani, B.; Lattanzio, M. Bioorg.
Med. Chem. Lett. 2014, 24, 5349. (b) Goodwin, D.; Simerska,
P.; Toth, I. Curr. Med. Chem. 2012, 19, 4451.
[22] Kuwana, T.; Bublitz, D. E.; Hoh, G. J. Am. Chem. Soc. 1960,
82, 5811.
[ 23 ] The addition of water to iminium, which results in
hydroxy-AA formation is reported: Miossec, B.; Rudyk, H.;
Toupet, L.; Danion-Bougot, R.; Danion, D. J. Chem. Soc., Perkin
Trans 1 1996, 1833.
[ 24 ] For report involving a radical chain mechanism-based
arylhydroxylation of styrenes under thermal conditions, see:
Kindt, S.; Wicht, K.; Heinrich, M. R. Angew. Chem. Int. Ed. 2016,
55, 8744.
[
6] Wright, T. H.; Bower, B. J.; Chalker, J. M.; Bernardes, G. J.
L.; Wiewiora, R.; Ng, W.-L.; Raj, R.; Faulkner, S.; Vallée, M. R.
J.; Phanumartwiwath, A.; Coleman, O. D.; Thézénas, M.-L.;
Khan, M.; Galan, S. R. G.; Lercher, L.; Schombs, M. W.;
Gerstberger, S.; Palm-Espling, M. E.; Baldwin, A. J.; Kessler, B.
M.; Claridge, T. D. W.; Mohammed, S.; Davis, B. G. Science
2016, 354, 553.
[
7] (a) For CS linkage in antimicrobial peptides, see: Kawulka,
[ 25 ] The unprotected 4-chlorophenylalanine (also known as
Fenclonine) is competitive inhibitor of tryptophan-5-hydroxylase,
see: Miyamoto, Y.; Watanabe, Y.; Tanaka, M. Regul. Pept. 2008,
145, 54.
K. E.; Sprules, T.; Diaper, C. M.; Whittal, R. M.; McKay, R. T.;
Mercier, P.; Zuber, P.; Vederas, J. C. Biochemistry 2004, 43,
3
385. (b) Rea, M. C.; Sit, C. S.; Clayton, E.; O’Connor, P. M.;
Whittal, R. M.; Zheng, J.; Vederas, J. C.; Ross, R. P.; Hill, C.
Proc. Natl. Acad. Sci. 2010, 107, 9352. (c) For CO based
intermediates in oxidation through peptidylglycine amidating
monooxygenase (PAM), see: Young, S. D.; Tamburini, P. P. J.
Am. Chem. Soc. 1989, 111, 1933. (d) Ramer, S. E.; Cheng, H.;
Palcic, M. M.; Vederas, J. C. J. Am. Chem. Soc. 1988, 110,
8526.
[
8 ] For a report on the employment of norcystine (i.e.,
mercaptoglycine) in gonadotropin releasing growth hormone
analogues, see: Samant, M. P.; Rivier, J. E. Org. Lett. 2006, 8,
361.
9] (a) For an example of thiol substitution, see: Kawulka, K.;
2
[
Sprules, T.; McKay, R. T.; Mercier, P.; Diaper, C. M.; Zuber, P.;
Vederas, J. C. J. Am. Chem. Soc. 2003, 125, 4726. (b) For a
report involving elimination, see: ref 10b. (c) For reduction to
generate UAA as racemic mixture, see: ref 12.
[
10] For oxidation of AA derivatives with t-BuOCl, see: (a)
Poisel, H.; Schmidt, U. Chem. Ber. 1975, 108, 2547. (b) Poisel,
H. Chem. Ber. 1977, 110, 942.
This article is protected by copyright. All rights reserved.